The inspection, detection, characterization and source determination of foreign particulate matter in parenteral drug products is a critical aspect to the drug manufacturing process. Methodologies exist to address many of these phases. However, a cohesive program is vital to any parenteral drug manufacturer to manage the entire particulate management lifecycle.
